| Secondary |
| Product Used For Unknown Indication |
23.7% |
| Drug Use For Unknown Indication |
21.1% |
| Anxiety |
9.3% |
| Agitation |
7.0% |
| Insomnia |
6.5% |
| Hypertension |
5.4% |
| Dementia Alzheimer's Type |
4.8% |
| Depression |
3.9% |
| Psychotic Disorder |
1.9% |
| Type 2 Diabetes Mellitus |
1.9% |
| Benign Prostatic Hyperplasia |
1.8% |
| Extrapyramidal Disorder |
1.7% |
| Unevaluable Event |
1.7% |
| Epilepsy |
1.6% |
| Memory Impairment |
1.6% |
| Pain |
1.6% |
| Alcoholism |
1.2% |
| Intentional Overdose |
1.2% |
| Neurosis |
1.2% |
| Ill-defined Disorder |
1.0% |
|
| Somnolence |
13.3% |
| Sudden Death |
6.7% |
| Vomiting |
6.7% |
| Malaise |
5.7% |
| Pruritus Generalised |
5.7% |
| Confusional State |
4.8% |
| Death |
4.8% |
| Eosinophilia |
4.8% |
| Pulmonary Embolism |
4.8% |
| Respiratory Disorder |
4.8% |
| Tachycardia |
4.8% |
| Cognitive Disorder |
3.8% |
| Disorientation |
3.8% |
| Hypernatraemia |
3.8% |
| Hyponatraemia |
3.8% |
| Pruritus |
3.8% |
| Thrombocytopenia |
3.8% |
| Urinary Tract Infection |
3.8% |
| Wrong Drug Administered |
3.8% |
| Abnormal Behaviour |
2.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
26.3% |
| Product Used For Unknown Indication |
11.7% |
| Pain |
7.1% |
| Dementia Alzheimer's Type |
6.3% |
| Depression |
5.7% |
| Hypertension |
5.3% |
| Prophylaxis |
5.3% |
| Anxiety |
5.1% |
| Rheumatoid Arthritis |
4.9% |
| Headache |
3.6% |
| Epilepsy |
2.4% |
| Urinary Tract Infection |
2.4% |
| Unevaluable Event |
2.2% |
| Insomnia |
2.1% |
| Abnormal Behaviour |
2.0% |
| Hepatitis C |
1.9% |
| Parkinson's Disease |
1.7% |
| Hypothyroidism |
1.5% |
| Diabetes Mellitus |
1.2% |
| Aggression |
1.1% |
|
| Renal Failure |
9.2% |
| Vasculitis |
9.2% |
| Malnutrition |
7.6% |
| Somnolence |
7.6% |
| Thrombocytopenia |
6.9% |
| International Normalised Ratio Increased |
5.3% |
| Myocardial Infarction |
5.3% |
| Urinary Retention |
5.3% |
| Epilepsy |
4.6% |
| Rhabdomyolysis |
4.6% |
| Death |
3.8% |
| Hyponatraemia |
3.8% |
| Malaise |
3.8% |
| Toxic Skin Eruption |
3.8% |
| Vomiting |
3.8% |
| Cholestasis |
3.1% |
| Eczema |
3.1% |
| Motor Dysfunction |
3.1% |
| Pulmonary Embolism |
3.1% |
| Rash Maculo-papular |
3.1% |
|
| Interacting |
| Drug Use For Unknown Indication |
98.4% |
| Convulsion |
1.6% |
|
| Drug Interaction |
33.3% |
| Pneumonia Aspiration |
33.3% |
| Traumatic Shock |
22.2% |
| Respiratory Distress |
11.1% |
|
